DCVC Bio invests in early-stage deep tech startups within the life sciences, focusing on computation-enhanced platforms that leverage AI and big data to generate new categories of treatments and products. Their strategy involves backing scientific teams that address critical health and environmental challenges, such as curing diseases, extending healthy lifespans, and producing sustainable food.
59% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (59% of deals). Average disclosed round size is $62.4M (across 22 rounds with reported amounts).
Portfolio
22
Fund Size
$1B
Top Stage
Series A
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
22 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Nilo Therapeutics | Series A | $101M | Oct 2025 |
 Solu Therapeutics | Series A | $41M | Apr 2025 |
| AAgZen Inc. | Series A | $10M | Mar 2025 |
 Umoja Biopharma | Series C | $100M | Jan 2025 |
| EElo Life Systems | Series A | $20.5M | Jan 2024 |
 Totus Medicines | Series B | $66M | Dec 2023 |
 Ascend Gene & Cell Therapies | Series A | $132.5M | May 2023 |
 Chroma Medicine | Series B | $135M | Mar 2023 |
| EElo Life Systems | Series A | $24.5M | Feb 2023 |
 Sabanto | Series A | $17M | Aug 2022 |
 Auron Therapeutics | Series A | $48M | Jul 2022 |
| UUnlearn.AI | Series B | $50M | Apr 2022 |
 Creyon Bio | Seed | $40M | Mar 2022 |
 Plexium, Inc. | Growth | $102M | Feb 2022 |
 MycoWorks | Series C | $125M | Jan 2022 |
| Totus Medicines | Series A | $40M | Dec 2021 |
| BBioPhero | Series A | $14.2M | Mar 2021 |
| MycoWorks | Series C | $125M | Jan 2021 |
| Umoja Biopharma | Series A | $53M | Nov 2020 |
| MycoWorks | Series B | $45M | Nov 2020 |
| MycoWorks | Series A | $17M | Dec 2019 |
 Frontier Medicines | Series A | $67M | Jun 2019 |
Top Co-Investors
Novo Holdings6 shared
Alexandria Venture Investments6 shared
Lux Capital3 shared
Casdin Capital3 shared
MPM Capital3 shared
Qiming Venture Partners USA3 shared
8VC3 shared
Mubadala Ventures3 shared
Northpond Ventures2 shared
Eli Lilly and Company2 shared
Pappas Capital2 shared
Deerfield2 shared
RA Capital Management2 shared
Cormorant Asset Management2 shared
SoftBank Vision Fund2 shared
Prime Movers Lab2 shared
SK Networks2 shared
The Column Group2 shared
Agfunder2 shared
Wireframe Ventures2 shared
Last updated: 8 March 2026